Zsolt Kulcsár1,2, Agnieszka Karol3, Peter W Kronen3,4, Pfundstein Svende3, Karina Klein3, Olivier Jordan5,6, Isabel Wanke7,8,9. 1. Service of Diagnostic and Interventional Neuroradiology, Geneva University Hospitals, Rue Gabrielle-Perret-gentil 4, 1211, Geneva, Switzerland. kulcsarzsolt22@gmail.com. 2. Interventional Work Research, CABMM, University of Zurich, Zurich, Switzerland. kulcsarzsolt22@gmail.com. 3. Musculoskeletal Research Unit, VETSUISSE, University of Zurich, Zurich, Switzerland. 4. Veterinary Anaesthesia Services-International, Winterthur, Switzerland. 5. School of Pharmaceutical Sciences, University of Geneva & University of Lausanne, Geneva, Switzerland. 6. Antia Therapeutics, Bern, Switzerland. 7. Interventional Work Research, CABMM, University of Zurich, Zurich, Switzerland. 8. Neuroradiology, Swiss Neuro Institute, Clinic Hirslanden, Zurich, Switzerland. 9. Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital of Essen, Essen, Germany.
Abstract
OBJECTIVES: To evaluate a novel, ready-to-use, iodinated polyvinyl alcohol polymer embolic implant. METHODS: Under good laboratory practice conditions, 26 pigs were investigated. A complex arteriovenous malformation (AVM) model was created in 16 animals, and a simple rete model was used in the remaining 10 animals. The novel material was used for embolization in 22 animals, and a commercially available liquid embolic material in 4 animals as a control group. Animals were killed at 2 days, 3 months and 6 months. Feasibility, efficacy and safety were evaluated radiologically, clinically and histologically. RESULTS: Preparation was easy, without risk of catheter clogging or adhesiveness. Embolic delivery was well controlled under subtracted fluoroscopy. Visibility was homogeneous throughout the injection and the material behaved cohesively upon delivery. Best lesion penetration was obtained with the use of proximal microballoon occlusion. Unforeseen over-dilution of the test material by DMSO prefilled in the microballoon hub changed the material properties and caused inadvertent cerebral embolization leading to death in five animals. This phenomenon was avoided by practical measures. The casts produced no beam-hardening artefacts on CT scans. Histology showed excellent biocompatibility. CONCLUSIONS: Embolization with this novel, iodinated, precipitating polymer was feasible and effective. Care should be taken during delivery to avoid over-dilution of the material by prefilled DMSO. The material is promising for embolization of AVMs and hypervascular lesions. KEY POINTS: • The intrinsically opaque precipitating polymer has adequate fluoroscopic visibility • The polymer does not induce shading or beam-hardening artefacts on CT • The novel liquid embolic material does not require lengthy preparation • Lack of implant adherence reduces the risk of entrapment of the delivery catheter.
OBJECTIVES: To evaluate a novel, ready-to-use, iodinated polyvinyl alcohol polymerembolic implant. METHODS: Under good laboratory practice conditions, 26 pigs were investigated. A complex arteriovenous malformation (AVM) model was created in 16 animals, and a simple rete model was used in the remaining 10 animals. The novel material was used for embolization in 22 animals, and a commercially available liquid embolic material in 4 animals as a control group. Animals were killed at 2 days, 3 months and 6 months. Feasibility, efficacy and safety were evaluated radiologically, clinically and histologically. RESULTS: Preparation was easy, without risk of catheter clogging or adhesiveness. Embolic delivery was well controlled under subtracted fluoroscopy. Visibility was homogeneous throughout the injection and the material behaved cohesively upon delivery. Best lesion penetration was obtained with the use of proximal microballoon occlusion. Unforeseen over-dilution of the test material by DMSO prefilled in the microballoon hub changed the material properties and caused inadvertent cerebral embolization leading to death in five animals. This phenomenon was avoided by practical measures. The casts produced no beam-hardening artefacts on CT scans. Histology showed excellent biocompatibility. CONCLUSIONS: Embolization with this novel, iodinated, precipitating polymer was feasible and effective. Care should be taken during delivery to avoid over-dilution of the material by prefilled DMSO. The material is promising for embolization of AVMs and hypervascular lesions. KEY POINTS: • The intrinsically opaque precipitating polymer has adequate fluoroscopic visibility • The polymer does not induce shading or beam-hardening artefacts on CT • The novel liquid embolic material does not require lengthy preparation • Lack of implant adherence reduces the risk of entrapment of the delivery catheter.
Authors: D P Link; J D Strandberg; R Virmani; K Blashka; F Mourtada; M A Samphilipo Journal: J Vasc Interv Radiol Date: 1996 Nov-Dec Impact factor: 3.464
Authors: Alejandro M Spiotta; Robert F James; Stephen R Lowe; Jan Vargas; Aquilla S Turk; M Imran Chaudry; Tarun Bhalla; Rashid M Janjua; John J Delaney; Stacey Quintero-Wolfe; Raymond D Turner Journal: J Neurointerv Surg Date: 2014-08-12 Impact factor: 5.836
Authors: O Dudeck; O Jordan; K T Hoffmann; A F Okuducu; I Husmann; T Kreuzer-Nagy; K Tesmer; P Podrabsky; H Bruhn; J Hilborn; D A Rüfenacht; E Doelker; R Felix Journal: AJNR Am J Neuroradiol Date: 2006-10 Impact factor: 3.825
Authors: Dominik F Vollherbst; Ruth Otto; Thuy Do; Hans U Kauczor; Martin Bendszus; Christof M Sommer; Markus A Möhlenbruch Journal: Interv Neuroradiol Date: 2018-07-04 Impact factor: 1.610